ome of the highlights of last week's teleconference include:
* Updates on hormonal treatments for women with advanced (metastatic)
breast cancer and in the extended adjuvant setting
* Findings from targeted therapy studies of Herceptin (trastuzumab)
and lapatinab
* Effects of Aromasin (exemestane) on bone density in women with early
stage breast cancer
* Aromasin versus tamoxifen as first-line treatment for advanced
(metastatic) disease
*Benefits of using a two-week schedule for chemotherapy (or dose-dense
approach) for early stage breast cancer
* Clinical trial results of Arimidex (anastrozole) and Femara
(letrozole) versus tamoxifen
* Comparing Taxol (every 3 weeks) versus Gemzar (gemcitabine) plus
Taxol, as frontline therapy for advanced (metastatic) breast cancer

We encourage you to take advantage of this free replay! You can listen
at any time that is convenient for you by clicking one of the links
below.

To listen using Real Player (for Mac users):
http://orion.calleci.com/servlet/estreamgetevent?id=3530&folder=webstream

To listen using Windows Media (for PC users):
http://orion.calleci.com/servlet/estreamgetevent?id=3532&folder=webstream

You will need Real Player Live or Windows Media Live to listen to the
program on your computer, visit http://www.lbbc.org/conferences.html
to download either application for free.